Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
Published Date: 02 Mar 2023
The legal team said the jury's decision could make medics think twice before allowing the injured to return to the field.
Read Full NewsA phase 2/3 trial evaluates the efficacy and safety of neoadjuvant therapy with gemcitabine-oxaliplatin, lenvatinib, and toripalimab in patients with high-risk intrahepatic cholangiocarcinoma.
Hypertensive disorders of pregnancy, chronic hypertension, and obesity are the primary risk factors for severe maternal morbidity.
Cannabis use disorder has a bidirectional and clinically meaningful association with major depressive disorder, new research suggests.
A new cohort study suggests that Medicaid expansion is associated with a lower mortality risk among patients with pancreatic cancer.
Upadacitinib may improve self-reported sleep quality at 3 months in patients with rheumatoid arthritis, with sustained benefits seen over the long term.
Approximately 40% of patients with muscle-invasive bladder cancer achieve a clinical complete response after neoadjuvant sacituzumab govitecan plus pembrolizumab, the SURE-02 trial finds.
Research is limited, but what has been done shows a possible connection.
1.
What Role Should Genomic Classifier Testing Play in Prostate Cancer?
2.
Efficacy and safety of intravenous chemotherapy in children with intraocular retinoblastoma
3.
Guidelines for cervical cancer screening and the risk of preterm birth in young women.
4.
Subcutaneous Cancer Immunotherapies Provide New Options for Physicians and Patients
5.
Veterans of the Navy have high lung cancer rates associated with asbestos use.
1.
Exploring the Mystery of Angiokeratomas on Scrotum: Causes, Symptoms and Treatment
2.
Unraveling the Mysteries of Metastasis: Exploring the Latest Advances in Cancer Research
3.
A Closer Look at Breast Cancer: Examining the Ultrasound Images
4.
Interplay of Brown Hair, Follicular Biology, and Hair Growth Inhibitors in Melanoma Pathogenesis
5.
Multiple Myeloma: Understanding the Basics
1.
International Lung Cancer Congress®
2.
Future NRG Oncology Meeting
3.
Genito-Urinary Oncology Summit 2026
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
An Eagles View - Evidence-based Discussion on Iron Deficiency Anemia- Panel Discussion III
2.
A Continuation to Deep Dive Into EGFR Mutation Positive Non-Small Cell Lung Cancer
3.
An In-Depth Look At The Signs And Symptoms Of Lymphoma- Further Discussion
4.
Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update) - Part II
5.
An Intro to The Multifaceted Advantages of CDK4/6 Inhibitors in HR+/HER2- Advanced Breast Cancer Clinical Studies.
Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
To get started please enter your email ID
Join to enhance your clinical skills and gain specialized in-depth medical knowledge